Closed

Provision of Clinical Trial Monitoring to the FaR-RMS Trial

Descriptions

The University of Birmingham Cancer Research Clinical Trials Unit are working on a collaboration with a large Pharmaceutical company to add a new arm to an existing study. The trial is a multicentre, randomised phase II trial evaluating the new therapy against a control arm in paediatric patients with relapsed/refractory rhabdomyosarcoma. Patients will receive therapy for up to 12 cycles (approx. 12 months) and will be followed-up for 5 years.

Timeline

Published Date :

31st Mar 2021 4 years ago

Deadline :

30th Apr 2021 4 years ago

Contract Start :

N/A

Contract End :

N/A

Tender Regions

Keywords

innovation delivery

prototype realization

bedside monitoring units

product testing delivery

R&D implementation

lab results integration

multi-parameter monitors

test ordering module

project coordination

experimental execution

decision support alert

clinical order entry

clinician dashboard

research planning

development execution

clinical pathway manager

medication reconciliation

patient monitoring systems

technical program management

radiology report interface

patient monitoring integration

end-to-end research services

clinical documentation tool

Let’s Get you Started ✍

Get to see all tender details more briefly

Already have an account ?

Workflows

Status :

Closed

Procedure :

Open procedure

Suitable for SME :

N/A

Nationwide :

No

Assign to :

Tender Progress :

0%

Details

Notice Type :

Tender

Tender Identifier :

IT-378-246-T: 2024 - 001

Tenderbase ID :

310724019

Low Value :

£100K

High Value :

£1000K

Buyer Information

Address :

Liverpool Merseyside , Merseyside , L13 0BQ

Website :

N/A

Procurement Contact

Name :

Tina Smith

Phone :

0151 252 3243

Email :

tina.smith@shared-ed.ac.uk